84.4% of cancer patients taking ivermectin + mebendazole for 6 months reported either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.

The largest real-world human study to date evaluating ivermectin and mebendazole in cancer patients is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.

Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” represents one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

https://www.thefocalpoints.com/p/breaking-largest-human-cancer-study?

 

How long will it take before ALL references to this study are removed from public consumption — Ivermectic costs $.50/dose (or less) while “Cancer treatments” can be Tens of Thousands of dollars. Is the medical objective to shut down Ivermectin completely – as was done with DMSO in the 1950’s!! Inexpensive and highly effective treatments that do NOT support the medical industry business model!